Islay Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.3K | Hold |
630
| – | – | 0.03% | 127 |
|
|
2025
Q1 | $44.5K | Hold |
630
| – | – | 0.03% | 120 |
|
|
2024
Q4 | $41.4K | Hold |
630
| – | – | 0.03% | 130 |
|
|
2024
Q3 | $44.5K | Hold |
630
| – | – | 0.03% | 127 |
|
|
2024
Q2 | $41.8K | Hold |
630
| – | – | 0.03% | 132 |
|
|
2024
Q1 | $42.8K | Hold |
630
| – | – | 0.03% | 131 |
|
|
2023
Q4 | $38.9K | Hold |
630
| – | – | 0.03% | 140 |
|
|
2023
Q3 | $37.2K | Hold |
630
| – | – | 0.03% | 139 |
|
|
2023
Q2 | $37.6K | Hold |
630
| – | – | 0.03% | 136 |
|
|
2023
Q1 | $36.8K | Hold |
630
| – | – | 0.04% | 142 |
|
|
2022
Q4 | $39.1K | Hold |
630
| – | – | 0.04% | 141 |
|
|
2022
Q3 | $36K | Hold |
630
| – | – | 0.04% | 159 |
|
|
2022
Q2 | $40K | Hold |
630
| – | – | 0.04% | 191 |
|
|
2022
Q1 | $41K | Hold |
630
| – | – | 0.03% | 201 |
|
|
2021
Q4 | $42K | Hold |
630
| – | – | 0.03% | 191 |
|
|
2021
Q3 | $38K | Hold |
630
| – | – | 0.03% | 209 |
|
|
2021
Q2 | $39K | Hold |
630
| – | – | 0.03% | 207 |
|
|
2021
Q1 | $37K | Hold |
630
| – | – | 0.03% | 188 |
|
|
2020
Q4 | $38K | Hold |
630
| – | – | 0.03% | 189 |
|
|
2020
Q3 | $34K | Hold |
630
| – | – | 0.04% | 189 |
|
|
2020
Q2 | $32K | Hold |
630
| – | – | 0.04% | 186 |
|
|
2020
Q1 | $28K | Buy |
+630
| New | +$28K | 0.04% | 174 |
|